Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,042 132,591
2025-03-28 Cioffi Christiana Marie Chief Strategy Officer Grant or award · Restricted Share Unit +10,000 160,000
2025-03-28 Sayad Pierre Sargis Chief Medical Officer Grant or award · Restricted Share Unit +10,000 160,000
2025-03-28 Evans Terry L Chief Commercial Officer Grant or award · Restricted Share Unit +10,000 160,000
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Restricted Share Unit +75,000 475,000
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +50,000 525,000
2025-03-28 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award · Restricted Share Unit +75,000 827,722
2025-03-28 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award · Stock Options +50,000 877,722
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Restricted Share Unit +75,000 75,000
2025-03-28 Hackman Jeffrey S. Chief Executive Officer Grant or award · Stock Options +50,000 450,000
2025-03-28 Evans Terry L Chief Commercial Officer Grant or award · Restricted Share Unit +10,000 10,000
2025-03-28 Cioffi Christiana Marie Chief Strategy Officer Grant or award · Restricted Share Unit +10,000 10,000
2025-03-05 Raykov Rosty Director Sale 10b5-1 −10,000 $6.79 $68K 68,725
2025-02-28 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,042 131,549
2025-02-28 Raykov Rosty Director Grant or award +2,431 78,725
2025-02-14 RALLIS CHRIS A Director Option exercise 10b5-1 +1,992 $2.51 $5K 54,206
2025-02-14 RALLIS CHRIS A Director Sale 10b5-1 −1,186 $6.82 $8K 53,020
2025-02-14 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −1,992 $2.51 $5K 182,706
2025-02-05 Raykov Rosty Director Sale 10b5-1 −10,000 $6.66 $67K 76,294
2025-01-31 Raykov Rosty Director Grant or award +2,431 86,294

Page 10 of 17 · 340 trades